Multiparameter Flow Cytometric Analysis Reveals Low Percentage of Bone Marrow Hematogones in Myelodysplastic Syndromes-Reference-Cited by-同舟云学术

Multiparameter Flow Cytometric Analysis Reveals Low Percentage of Bone Marrow Hematogones in Myelodysplastic Syndromes

Published:2008-02 Issue:2 Volume:129 Page:300-308
ISSN:0002-9173
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:Am J Clin Pathol

Author:

Maftoun-Banankhah Sepideh,Maleki Atousa,Karandikar Nitin J.,Arbini Arnaldo A.,Fuda Franklin S.,Wang Huan-You,Chen Weina

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/129/2/300/4988544/ajcpath129-0300.pdf

Reference33 articles.

1. Aul C, Germing U, Gattermann N, et al. Increasing incidence of myelodysplastic syndromes: real or fictitious? Leuk Res. 1998;22:93-100.

2. Burning RD, Bennett JM, Flandrin G, et al. Myelodysplastic syndromes: introduction. In: Jaffe ES, Harris NL, Stein H, et al, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:63-67. World Health Organization Classification of Tumours.

3. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002;100:2292-2302.

4. Ramos F, Fernandez-Ferrero S, Suarez D, et al. Myelodysplastic syndrome: a search for minimal diagnostic criteria. Leuk Res. 1999;23:283-290.

5. List AF, Vardiman J, Issa JP, et al. Myelodysplastic syndromes. Hematology Am Soc Hematol Educ Program. 2004:297-317.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Guide to the Diagnosis of Myeloid Neoplasms: A Bone Marrow Pathology Group Approach;American Journal of Clinical Pathology;2023-06-30

2. Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1;Blood Advances;2021-08-24

3. Exploring blast composition in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms: CD45RA and CD371 improve diagnostic value of flow cytometry through assessment of myeloblast heterogeneity and stem cell aberrancy;Cytometry Part B: Clinical Cytometry;2020-12-24

4. Immunophenotypic characteristics of juvenile myelomonocytic leukaemia and their relation with the molecular subgroups of the disease;British Journal of Haematology;2020-09-23

5. The prognostic significance of hematogones and CD34+ myeloblasts in bone marrow for adult B-cell lymphoblastic leukemia without minimal residual disease;Scientific Reports;2019-12